NEW YORK (GenomeWeb News) – Contract research organization Reaction Biology (RBC) said today that it has signed an agreement with Cisbio Bioassays for distribution of its epigenetic proteins.

The agreement gives Cisbio global rights to co-market and sell RBC's epigenetic proteins. Cisbio can include these proteins in its portfolio of assays, including recently added assays for assessing epigenetic targets like methyltransferases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.